Global Patterns of Care for HER2/Neu Overexpressing Breast Cancer

被引：0
|
作者：
Chavarri-Guerra, Y. [1 ]
Liedke, P. [1 ]
Symecko, H. [1 ]
Moy, B. [1 ]
Higgins, M. [1 ]
St Louis, J. [1 ]
Finkelstein, D. [1 ]
Goss, P. [1 ]
机构：
[1] Massachusetts Gen Hosp, Avon Int Breast Canc Program, Boston, MA 02114 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P1-12-26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-12-26
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Extravascular distribution of trastuzumab in Her2/neu overexpressing xenografts
    Baker, Jennifer H. E.
    Lindquist, Kirstin E.
    Huxham, Lynsey A.
    Kyle, Alastair H.
    Sy, Jonathan T.
    Minchinton, Andrew I.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3473S - 3473S
  • [32] ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
    Isabel Pinhel
    Margaret Hills
    Suzanne Drury
    Janine Salter
    Georges Sumo
    Roger A'Hern
    Judith M Bliss
    Ivana Sestak
    Jack Cuzick
    Peter Barrett-Lee
    Adrian Harris
    Mitch Dowsett
    Breast Cancer Research, 14
  • [33] ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
    Pinhel, Isabel
    Hills, Margaret
    Drury, Suzanne
    Salter, Janine
    Sumo, Georges
    A'Hern, Roger
    Bliss, Judith M.
    Sestak, Ivana
    Cuzick, Jack
    Barrett-Lee, Peter
    Harris, Adrian
    Dowsett, Mitch
    BREAST CANCER RESEARCH, 2012, 14 (02)
  • [34] Trastuzumab (T) plus oral vinorelbine (OV) in patients with advanced breast cancer (ABC) overexpressing Her2/neu
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 168 - 168
  • [35] Geldanamycin inhibits proliferation and motility of Her2/neu-overexpressing SKBr3 breast cancer cells
    任予
    王珂
    何建军
    陈武科
    马清涌
    Journal of Pharmaceutical Analysis, 2008, (04) : 235 - 241
  • [36] Her2/neu in local metastases and primary focus of breast cancer
    Sazonov, S.
    Konyshev, K.
    VIRCHOWS ARCHIV, 2015, 467 : S55 - S55
  • [37] Association between HER2/neu overexpression and calcifications in breast cancer
    Christy, C. J.
    Rishi, M.
    Schwartz, J.
    Grube, B. J.
    Bossuyt, V.
    Philpotts, L.
    DiGiovanna, M. P.
    Tavassoli, F.
    Lannin, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Prognostic and predictive value of HER2/neu oncogene in breast cancer
    Masood, S
    Bui, MM
    MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 59 (02) : 102 - 108
  • [39] HER2/neu multicentric study in breast cancer at the Comunidad Valenciana
    Felipe-Ponce, V.
    Rubio, L.
    Rubio-Alcala, M. C.
    Sentamans, C. Villalba
    Garcia, A.
    Martinez, M. J. Artes
    Vera-Sempere, F. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (05): : 687 - 687
  • [40] Targeted Therapy in Metastatic Breast Cancer: The HER2/neu Oncogene
    Harbeck, Nadia
    Pegram, Mark D.
    Rueschoff, Josef
    Moebus, Volker
    BREAST CARE, 2010, 5 : 3 - 7
12345